BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Johnson and Johnson

Generated: March 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021365

« Back to Dashboard

NDA 021365 describes LEXAPRO, which is a drug marketed by Allergan Sales Llc and is included in two NDAs. It is available from fourteen suppliers. There are two patents protecting this drug and two Paragraph IV challenges. Additional details are available on the LEXAPRO profile page.

The generic ingredient in LEXAPRO is escitalopram oxalate. There are twenty-six drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the escitalopram oxalate profile page.
Summary for 021365
Applicant:Allergan Sales Llc
Ingredient:escitalopram oxalate
Therapeutic Class:Antidepressants
Pharmacology for NDA: 021365
Mechanism of ActionSerotonin Uptake Inhibitors
Suppliers and Packaging for NDA: 021365
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEXAPRO escitalopram oxalate SOLUTION;ORAL 021365 NDA Allergan, Inc. 0456-2101 N 0456-2101-08

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrengthEQ 5MG BASE/5ML
Approval Date:Nov 27, 2002TE:AARLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.